Our primary goal was to evaluate the effect of methylation levels for SEPT9 and SDC2 in leukocytes on the performance of ColoDefense test, and our secondary aim was to further validate the plasma test for CRC early detection in a validation set. The gene discussed is SDC2; the disease is colorectal carcinoma.